197 related articles for article (PubMed ID: 15297198)
1. E-cadherin and catenins in early squamous cervical carcinoma.
Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
3. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
[TBL] [Abstract][Full Text] [Related]
5. Markers of apoptosis in stage IB squamous cervical carcinoma.
Van de Putte G; Holm R; Lie AK; Baekelandt M; Kristensen GB
J Clin Pathol; 2005 Jun; 58(6):590-4. PubMed ID: 15917408
[TBL] [Abstract][Full Text] [Related]
6. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
7. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
8. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
9. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
12. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A
Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126
[TBL] [Abstract][Full Text] [Related]
13. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
15. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
[TBL] [Abstract][Full Text] [Related]
16. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
Bagutti C; Speight PM; Watt FM
J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
[TBL] [Abstract][Full Text] [Related]
17. Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma.
Cheng Y; Zhou Y; Jiang W; Yang X; Zhu J; Feng D; Wei Y; Li M; Yao F; Hu W; Xiao W; Ling B
Hum Pathol; 2012 Aug; 43(8):1213-20. PubMed ID: 22221700
[TBL] [Abstract][Full Text] [Related]
18. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
19. alpha-, beta- and chi-catenin expression in human pancreatic cancer.
Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M
Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
Zhou YN; Li M
Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]